ABOUT VISTA PARTNERS

Vista Partners offers free, exclusive insight and research on the Dow 30 and Select Emerging Growth companies....

Browse Latest Coverage Learn More

Stay informed. Stay Competitive.

Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly, and quarterly investing ideas, strategies, and market insights.





We value your privacy and will never share your information. Click here to learn more about all the great features offered in our newsletter.

The Latest

Vista Current Coverage

Breast Cancer Innovator Atossa Genetics Accepts Subscriptions For ~$13.4MM Gross Proceeds Rights Offering

Seattle based Atossa Genetics Inc. (NasdaqCM: ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast condition,  announced today that the Company’s previously announced rights offering (“the Rights Offering”) expired on Thursday, May 24, 2018 and these...

“The GE Story Picks Up Steam With Wabtec Deal”

Wabtec Corporation is a leading global provider of equipment, systems and value-added services for transit and freight rail.  Through its subsidiaries, the company manufactures a range of products for locomotives, freight cars, and passenger transit vehicles. The company also builds new switcher and commuter locomotives...

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD

Dow 30

22,350
close
+0.4%
Week
+13.1%
YTD